Lung Cancer

Lung cancer is the world's most common cancer and kills more people than any other cancer. In 2008, approximately 1.52 million new cases of lung cancer were diagnosed worldwide, with 1.31 million people dying from the disease.(14) In the United States, an estimated 161,840 deaths, accounting for 29 percent of all cancer deaths, occurred in 2008, according to the American Cancer Society (ACS).

Lung Cancer

Lung cancer is a common and very serious form of cancer, with more than 40,000 people diagnosed with the condition each year in the UK. The symptoms of lung cancer do not present in the early stages, but when symptoms do eventually present, they usually include the following:

Lung Cancer Causes

Lung Cancer Symptoms

Lung Cancer Diagnosis

Epidemiology of Lung Cancer

Lung Cancer Treatments

Lung Cancer Research

Lung Cancer Questions

How to Prevent Lung Cancer

Lung Cancer Genetics

Lung Cancer Pathogenesis

What Causes Lung Cancer in Non-Smokers?

See more featured articles »

Lung Cancer: Radiotherapy and Chemotherapy

Types of Lung Cancer Surgery

Lymph Nodes in Lung Cancer

Pulmonary Resection in Lung Cancer

Palliative and End-of-Life Care in Lung Cancer

Secondary Lung Cancer

Carcinogens in Cigarette Smoke

Lung Cancer Screening Procedure

Lung Cancer and Electrolyte Imbalances

Lung Cancer Risk Factors

Everything You Need to Know About Giving Up Cigarettes

Immunotherapy: The Future of Lung Cancer Treatment?

Lung Plethysmography Procedure

Pulmonary Transplant (Lung Transplant)

What are the Survival Rates for Lung Cancer?

Exploring Diversity in Lung Cancer: Impact on Incidence, Prognosis, and Treatment Strategies

Lung Cancer in Women: Understanding the Increasing Risk

Latest Lung Cancer News and Research

Breakthrough research reveals how to target malignant DNA in aggressive cancers

Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the most aggressive cancers, paving the way for future treatments.

9 Nov 2024

New discovery could lead to better treatments for drug-resistant leukemia

Scientists from Duke-NUS Medical School and their collaborators have identified an inherited genetic variation prevalent among East Asians that contributes to drug resistance, driving the aggressive growth of cancer cells in patients with chronic myeloid leukemia.

8 Nov 2024

Artificial cilia system monitors mucus conditions in human airways

Xiaoguang Dong, assistant professor of mechanical engineering, is leading a team of researchers that has developed a system of artificial cilia capable of monitoring mucus conditions in human airways to better detect infection, airway obstruction, or the severity of diseases like Cystic Fibrosis (CF), Chronic Obstructive Pulmonary Diseases (COPD) and lung cancer.

7 Nov 2024

New SCLC biomarkers enable advances in precision medicine approaches

A new research paper was published in Oncotarget's Volume 15 on October 11, 2024, entitled "Relationship between the expressions of DLL3, ASC1, TTF-1 and Ki-67: First steps of precision medicine at SCLC"

6 Nov 2024

Assessing recurrence risk with ctDNA-based MRD detection in NSCLC patients

In operable non-small cell lung cancer (NSCLC), molecular residual disease (MRD) detection via circulating tumor DNA (ctDNA) has emerged as a promising approach to identify individuals at high risk of disease recurrence and potentially guide adjuvant therapy decisions.

6 Nov 2024

Stanford researchers unveil the key role of extrachromosomal DNA in cancer

A trio of research papers from Stanford Medicine researchers and their international collaborators transforms scientists' understanding of how small DNA circles -; until recently dismissed as inconsequential -; are major drivers of many types of human cancers.

6 Nov 2024

Nanoscale sensor detects lung cancer through breath chemistry

Exhaled breath contains chemical clues to what's going on inside the body, including diseases like lung cancer.

6 Nov 2024

World’s first comparative study shows safety of single-port robotic thymectomy

A Joint research team (Prof. Jun-hee Lee, Hyun-koo Kim, Jin-Wook Hwang, Jae-Ho Chung, the Department of Thoracic and Cardiovascular Surgery, Korea University College of Medicine) Announced the world's first compartive results of single-port robotic thymectomy using the single-port robotic system.

6 Nov 2024

$2.5 million grant supports lung cancer screening for marginalized communities

A multidisciplinary team of experts in lung cancer screening and implementation science from the UCLA Health Jonsson Comprehensive Cancer Center, the David Geffen School of Medicine at UCLA and the UCLA Fielding School of Public Health was awarded a $2.5 million grant from the Bristol Myers Squibb Foundation, an independent charitable organization, to spearhead a new initiative aimed at reducing disparities in lung cancer screening across Los Angeles County.

4 Nov 2024

Low awareness of lung cancer screening raises concerns

There is a lung cancer screening test that is saving lives – and yet most people who could be getting the test have never heard of it or never talked about it with a doctor.

4 Nov 2024

NCCN leaders collaborate to enhance cancer care in Vietnam

As part of ongoing work to define and advance high-quality cancer care globally, leaders from the National Comprehensive Cancer Network (NCCN)-;an alliance of leading cancer centers in the United States-;will be in Vietnam today to collaborate on improving cancer care standards throughout the country.

1 Nov 2024

Quitting smoking after cancer diagnosis can add years to patient lives

Quitting smoking within six months after a cancer diagnosis adds an average of two years to a patient's life.

1 Nov 2024

New therapeutic target overcomes ovarian cancer immunotherapy resistance

Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way that ovarian cancer tumors manipulate their environment to resist immunotherapy and identified a drug target that could overcome that resistance.

1 Nov 2024

Research reveals role of IGFBP3 in human lung development

Researchers of the University of Barcelona and the August Pi y Sunyer Biomedical Research Institute (IDIBAPS) have shown that the IGFBP3 protein plays a relevant role in human lung development.

1 Nov 2024

New technology streamlines drug discovery using single-molecule tracking

New drug discovery is a critical step for improving patients' lives. First, researchers must identify molecules in the body's cells that help drive disease, as these are potential targets for new drugs. The next step is to screen candidate drugs that can hit those targets.

1 Nov 2024

Long-term air pollution exposure increases asthma risk in children and adults

Researchers review existing evidence on the effects of long-term exposure to air pollution in the form of fine particulate matter on the risk of developing asthma.

30 Oct 2024

Study identifies six cancer susceptibility genes

Identification of six cancer susceptibility genes offers new insights into genetic risk factors, potentially enhancing early detection and treatment strategies.

29 Oct 2024

Study uncovers six cancer susceptibility genes

Scientists at deCODE genetics/Amgen, and their collaborators have discovered six novel genes with rare germline variants that associate with cancer risk. The findings are published today in Nature Genetics under the title "Gene-based burden tests of rare germline variants identify six cancer susceptibility genes".

29 Oct 2024

EBUS-TBNA proves effective for tumor molecular analysis in lung cancer

Tumor molecular analysis using next-generation sequencing (NGS) is the standard of care for guiding lung cancer treatment. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive technique used to sample mediastinal lymph nodes for diagnosing and staging lung cancer.

28 Oct 2024